Blood Lipids and Cardiovascular Disease: A Mendelian Randomization Study
DOI:
https://doi.org/10.62051/qamtcg89Keywords:
Mendelian randomization; HDL-C; LDL-C; triglycerides; causal inference; cardiovascular disease.Abstract
Blood lipids have been considered critical risk factors for cardiovascular disease (CVD). The causal relationship between blood lipids (HDL-C, LDL-C and triglycerides) and cardiovascular disease remains uncertain despite negative and positive associations observed in observational studies, which are susceptible to confounding and reverse causation. This study aimed to investigate the potential causal relationship between the three types of blood lipids and CVD using a two-sample Mendelian randomization (TSMR) approach. Instrumental variables (IVs) representing independent genetic variants associated with HDL-C, LDL-C and triglycerides were derived from the UK Biobank consortium, encompassing genetic data from more than 400,000 individuals. Outcome data for CVD events, including heart disease, stroke, atherosclerosis and so on, were obtained from FinnGen consortium. TSMR analyses were conducted using various methods, such as inverse variance weighted (IVW), MR-Egger regression, and weighted median estimator (WME), to explore the causal relationship between HDL-C, LDL-C and triglycerides levels and CVD events. The results from the Mendelian randomization (MR) analyses suggest a potential causal association between elevated HDL-C, LDL-C and triglycerides levels and CVD events, which indicates that increasing the level of HDL-C and restricting the level of LDL-C and triglycerides are possibly effective methods for the prevention of CVD.
Downloads
References
Jusic A, Thomas PB, Wettinger SB, Dogan S, Farrugia R, Gaetano C, Tuna BG, Pinet F, Robinson EL, Tual-Chalot S, Stellos K, Devaux Y; EU-CardioRNA COST Action CA17129. Noncoding RNAs in age-related cardiovascular diseases. Ageing Res Rev. 2022 May;77:101610. doi: 10.1016/j.arr.2022.101610. Epub 2022 Mar 23. PMID: 35338919.
Jokinen E. Obesity and cardiovascular disease. Minerva Pediatr. 2015 Feb;67(1):25-32. Epub 2014 Nov 11. PMID: 25387321.
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22. PMID: 33882682; PMCID: PMC8493650.
Austin MA. Plasma triglycerides as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol. 1989 Feb;129(2):249-59. doi: 10.1093/oxfordjournals.aje.a115130. PMID: 2643302.
Esan O, Wierzbicki AS. Triglycerides and cardiovascular disease. Curr Opin Cardiol. 2021 Jul 1;36(4):469-477. doi: 10.1097/HCO.0000000000000862. PMID: 33797418.
Schmidt KA, Cromer G, Burhans MS, Kuzma JN, Hagman DK, Fernando I, Murray M, Utzschneider KM, Holte S, Kraft J, Kratz M. Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial. Am J Clin Nutr. 2021 Sep 1;114(3):882-892. doi: 10.1093/ajcn/nqab131. PMID: 34258627; PMCID: PMC8408839.
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: A review. Res Synth Methods. 2019 Dec;10(4):486-496. doi: 10.1002/jrsm.1346. Epub 2019 Apr 23. PMID: 30861319; PMCID: PMC6973275.
Ma M, Zhi H, Yang S, Yu EY, Wang L. Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study. Nutrients. 2022 Apr 29;14(9):1878. doi: 10.3390/nu14091878. PMID: 35565843; PMCID: PMC9101688.
Ma M, Zhi H, Yang S, Yu EY, Wang L. Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study. Nutrients. 2022 Apr 29;14(9):1878. doi: 10.3390/nu14091878. PMID: 35565843; PMCID: PMC9101688.
Yin KJ, Huang JX, Wang P, Yang XK, Tao SS, Li HM, Ni J, Pan HF. No Genetic Causal Association Between Periodontitis and Arthritis: A Bidirectional Two-Sample Mendelian Randomization Analysis. Front Immunol. 2022 Jan 26;13:808832. doi: 10.3389/fimmu.2022.808832. PMID: 35154127; PMCID: PMC8825874.
Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011 Jun;40(3):755-64. doi: 10.1093/ije/dyr036. Epub 2011 Mar 16. PMID: 21414999.
Liu K, Zou J, Fan H, Hu H, You Z. Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study. Front Immunol. 2022 Sep 8;13:930318. doi: 10.3389/fimmu.2022.930318. PMID: 36159877; PMCID: PMC9496187.
Xu J, Zhang S, Tian Y, Si H, Zeng Y, Wu Y, Liu Y, Li M, Sun K, Wu L, Shen B. Genetic Causal Association between Iron Status and Osteoarthritis: A Two-Sample Mendelian Randomization. Nutrients. 2022 Sep 6;14(18):3683. doi: 10.3390/nu14183683. PMID: 36145059; PMCID: PMC9501024.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017 May;32(5):377-389. doi: 10.1007/s10654-017-0255-x. Epub 2017 May 19. Erratum in: Eur J Epidemiol. 2017 Jun 29;: PMID: 28527048; PMCID: PMC5506233.
Miao R, Li J, Meng C, Li Y, Tang H, Wang J, Deng P, Lu Y. Diet-Derived Circulating Antioxidants and Risk of Stroke: A Mendelian Randomization Study. Oxid Med Cell Longev. 2022 Jan 17;2022:6457318. doi: 10.1155/2022/6457318. PMID: 35082970; PMCID: PMC8786473.
Guan M, Yan L, Li R, Xu Y, Chen D, Li S, Ma F, Zhang X. Integration of leave-one-out method and real-time live cell reporter array system to assess the toxicity of mixtures. Environ Res. 2022 Nov;214(Pt 3):114110. doi: 10.1016/j.envres.2022.114110. Epub 2022 Aug 17. PMID: 35985486.
Weitao Shen, Ziguang Song, Xiao Zhong, Mei Huang, Danting Shen, Pingping Gao, Xiaoqian Qian, Mengmeng Wang, Xiubin He, Tonglian Wang, Shuang Li, Xiang Song. 2022. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1: e36. https://doi.org/10.1002/imt2.36.
Shen, et al. 2022. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1(3): e36. https://doi.org/10.1002/imt2.36.
Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL-C Cholesterol, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2020 May 5;75(17):2122-2135. doi: 10.1016/j.jacc.2020.02.059. PMID: 32354380; PMCID: PMC8064770.
Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV, Saini AK. Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis. Oxid Med Cell Longev. 2020 Sep 15;2020:5245308. doi: 10.1155/2020/5245308. PMID: 33014272; PMCID: PMC7512065.
Budoff M. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. Am J Cardiol. 2016 Jul 1;118(1):138-45. doi: 10.1016/j.amjcard.2016.04.004. Epub 2016 Apr 20. PMID: 27184174.
Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, Herzog EL, Kang I, Pisani MA, Yu S, Zhang C, Ring AM, Young LH, Medzhitov R. GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell. 2019 Aug 22;178(5):1231-1244.e11. doi: 10.1016/j.cell.2019.07.033. Epub 2019 Aug 8. PMID: 31402172; PMCID: PMC6863354.
Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022 May;72(5):986-988. doi: 10.47391/JPMA.22-63. PMID: 35713073.
Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021 Jun;119:154766. doi: 10.1016/j.metabol.2021.154766. Epub 2021 Mar 22. PMID: 33766485.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







